Kaplan-Meier estimates of efficacy end points in the overall intent-to-treat population. Investigator-assessed PFS (A), OS (B), EFS (C), and DOR (D). Log-rank test and Cox proportional hazards regression model were used to compare overall PFS and OS across treatment arms. EFS, event-free survival.